MOLECULAR DRUG DISCOVERY OF POTENTIAL INHIBITOR OF COVID–19 USING SEVERAL MEDICINAL PLANT INGREDIENTS: A PROMISING THERAPY FOR VIRAL DISEASE

Author:

Mollaamin FatemehORCID,Monajjemi Majid

Abstract

This research article aims to investigate the compounds of apigenine--7--glucoside, catechin, demethoxycurcumine, kaempferol, naringenin, oleuropein and quercetin extracted from \textit{Goji berries, Green tea, Turmeric, Chinese cabbage, Citrus fruit, Olive} and \textit{Chili pepper}, respectively, as a probable anti pandemic Covid19 receptor derived from medicinal plants. The physicochemical properties including heat of formation, Gibbs free energy, electronic energy, charge distribution have been evaluated for the active sites of natural drugs which can be proposed for Covid19 treatment. These phytochemicals can be attached to the active site of the database amino acids fragment of Tyr160--Met161--His162 as the selective zone of the Covid19 due to formation of hydrogen bonding. The theoretical calculations were done at various levels of theory to gain was more accurate equilibrium geometrical results, and IR spectral data for each of the complex proposed drugs of N--terminal or O--terminal auto--cleavage substrate were individually determined to elucidate the structural flexibility and substrate binding of seven medicinal plants jointed to active site of Covid19 molecule. A comparison of these structures with two configurations provides new insights for the design of substrate--based anti--targeting Covid19. This indicates a feasible model for designing wide--spectrum of anti--Covid19 drugs. The structure-based optimization of these structures has yielded two more efficacious lead compounds, N and O atoms through forming the hydrogen bonding with potent anti--Covid19

Publisher

Universidad Nacional de Colombia

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3